Literature DB >> 32320500

Dupilumab for the treatment of chronic actinic dermatitis.

Nayha Patel1,2, Sasank Konda2, Henry W Lim2.   

Abstract

Entities:  

Year:  2020        PMID： 32320500     DOI： 10.1111/phpp.12566

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN： 0905-4383            Impact factor:   3.135


× No keyword cloud information.
  3 in total

1.  Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature.

Authors:  Jiaoquan Chen; Huaping Li; Huilan Zhu
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-12-30

2.  Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series.

Authors:  Kamran Ali; Liming Wu; HaiYue Lou; Jianbo Zhong; YunMi Qiu; JiaYang Da; JingPeng Shan; KaiNing Lu
Journal:  Front Med (Lausanne)       Date:  2022-02-24

Review 3.  NRF2 in dermatological disorders: Pharmacological activation for protection against cutaneous photodamage and photodermatosis.

Authors:  Shirin Kahremany; Lukas Hofmann; Arie Gruzman; Albena T Dinkova-Kostova; Guy Cohen
Journal:  Free Radic Biol Med       Date:  2022-06-23       Impact factor: 8.101
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.